Institutions / Ikarian Capital, LLC
Ikarian Capital, LLC
CIK 1778253 · Institution · as of Dec 31, 2025
Portfolio value
$772.56M
Positions
135
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 135 →
| Company | Value | % of portfolio |
|---|---|---|
| Terns Pharmaceuticals, Inc. | $64.49M | 8.3% |
| Cidara Therapeutics Inc | $60.36M | 7.8% |
| Abivax SA | $29.13M | 3.8% |
| Jazz Pharmaceuticals PLC | $27.26M | 3.5% |
| Maze Therapeutics, Inc. | $26.71M | 3.5% |
| Praxis Precision Medicines, Inc. | $25.52M | 3.3% |
| Rapt Therapeutics Inc | $22.53M | 2.9% |
| Kodiak Sciences Inc.KOD | $20.13M | 2.6% |
| Olema Pharmaceuticals, Inc. | $18.97M | 2.5% |
| Vaxcyte, Inc. | $17.47M | 2.3% |
| Capricor Therapeutics, Inc. | $16.68M | 2.2% |
| Ionis Pharmaceuticals Inc | $15.98M | 2.1% |
| Fulcrum Therapeutics, Inc. | $15.56M | 2.0% |
| ELI LILLY & Co | $14.85M | 1.9% |
| Relmada Therapeutics, Inc. | $14.82M | 1.9% |
| Amgen Inc | $14.73M | 1.9% |
| CytomX Therapeutics, Inc. | $13.52M | 1.7% |
| Pharvaris N.V. | $13.51M | 1.7% |
| Connect Biopharma Hldgs Ltd | $13.50M | 1.7% |
| Bright Minds Biosciences Inc. | $12.44M | 1.6% |
| Tenax Therapeutics, Inc. | $11.80M | 1.5% |
| Revolution Medicines, Inc. | $11.00M | 1.4% |
| Cytokinetics Inc | $10.97M | 1.4% |
| Spruce Biosciences, Inc.SPRB | $10.57M | 1.4% |
| Celcuity Inc.CELC | $10.53M | 1.4% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.